Literature DB >> 27881873

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.

J Bordini1,2, S Galvan1, M Ponzoni3, M T S Bertilaccio4,5, M Chesi6, P L Bergsagel6, C Camaschella1,2, A Campanella1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27881873     DOI： 10.1038/leu.2016.346

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

Authors:  Zhimin Gu; He Wang; Jiliang Xia; Ye Yang; Zhendong Jin; Hongwei Xu; Jumei Shi; Ivana De Domenico; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

2.  Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.

Authors:  Alain Toledano; Elisabeth Luporsi; Jean François Morere; Florian Scotté; Kamel Laribi; Jérôme Barrière; Philippe Huot-Marchand; Ladan Duvillié; Victor Hugo Concas; Roland Bugat
Journal:  Support Care Cancer       Date:  2015-04-29       Impact factor: 3.603

Review 3.  Two to tango: regulation of Mammalian iron metabolism.

Authors:  Matthias W Hentze; Martina U Muckenthaler; Bruno Galy; Clara Camaschella
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

4.  Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.

Authors:  Jessica Bordini; Maria Teresa Sabrina Bertilaccio; Maurilio Ponzoni; Isabella Fermo; Marta Chesi; P Leif Bergsagel; Clara Camaschella; Alessandro Campanella
Journal:  Haematologica       Date:  2015-02-24       Impact factor: 9.941

5.  Iron increases the susceptibility of multiple myeloma cells to bortezomib.

Authors:  Alessandro Campanella; Paolo Santambrogio; Francesca Fontana; Michela Frenquelli; Simone Cenci; Magda Marcatti; Roberto Sitia; Giovanni Tonon; Clara Camaschella
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

6.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC.

Authors:  K J Wu; A Polack; R Dalla-Favera
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

Review 7.  Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species.

Authors:  Yuichiro Shimizu; Linda M Hendershot
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

8.  Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.

Authors:  Michael Hedenus; Torbjörn Karlsson; Heinz Ludwig; Beate Rzychon; Marcel Felder; Bernard Roubert; Gunnar Birgegård
Journal:  Med Oncol       Date:  2014-11-06       Impact factor: 3.064

Review 9.  Oxidative protein folding in eukaryotes: mechanisms and consequences.

Authors:  Benjamin P Tu; Jonathan S Weissman
Journal:  J Cell Biol       Date:  2004-02-02       Impact factor: 10.539

10.  Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.

Authors:  P Leif Bergsagel; W Michael Kuehl; Maurizio Affer; Marta Chesi; Wei-Dong G Chen; Jonathan J Keats; Yulia N Demchenko; Anna V Roschke; Scott Van Wier; Rafael Fonseca
Journal:  Leukemia       Date:  2014-02-12       Impact factor: 11.528
View more
  5 in total

Review 1.  The Role of Iron in Benign and Malignant Hematopoiesis.

Authors:  Sayantani Sinha; Joana Pereira-Reis; Amaliris Guerra; Stefano Rivella; Delfim Duarte
Journal:  Antioxid Redox Signal       Date:  2021-01-07       Impact factor: 7.468

2.  The iron chelator deferoxamine decreases myeloma cell survival.

Authors:  Feifei Yang; Zhaoxian Wu; Dan Dai; Lei Zhang; Xiuqun Zhang; Xuezhong Zhang; Yanli Xu
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

Review 3.  Iron metabolism and iron disorders revisited in the hepcidin era.

Authors:  Clara Camaschella; Antonella Nai; Laura Silvestri
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies.

Authors:  Jessica Bordini; Federica Morisi; Fulvia Cerruti; Paolo Cascio; Clara Camaschella; Paolo Ghia; Alessandro Campanella
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

Review 5.  The Multifaceted Role of Heme in Cancer.

Authors:  Veronica Fiorito; Deborah Chiabrando; Sara Petrillo; Francesca Bertino; Emanuela Tolosano
Journal:  Front Oncol       Date:  2020-01-15       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.